Amphastar Pharmaceuticals

^{Priced, Nasdaq: AMPH}

Produces difficult-to-manufacture injectable and inhalable drugs.

Industry: Health Care

First Day Return: +25.0%

AMPH

Produces difficult-to-manufacture injectable and inhalable drugs.

IPO News for Amphastar Pharmaceuticals

US IPO Pricing Recap: GoPro captures extreme gains in 11 IPO week 06/30/14
Amphastar Pharmaceuticals prices IPO at $7, below the range 06/25/14
19 US IPOs planned for the week of Jun 23 06/23/14

IPO Data
IPO Date	06/24/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$56
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.amphastar.com
Headquarters	Rancho Cucamonga, CA, United States
Founded	1996
Employees at IPO	1,217

IPO News for Amphastar Pharmaceuticals

US IPO Pricing Recap: GoPro captures extreme gains in 11 IPO week 06/30/14
Amphastar Pharmaceuticals prices IPO at $7, below the range 06/25/14
19 US IPOs planned for the week of Jun 23 06/23/14

Amphastar Pharmaceuticals (AMPH) Performance